A

ABIOMED Inc
LSE:0H7S

Watchlist Manager
ABIOMED Inc
LSE:0H7S
Watchlist
Price: 381.02 USD 0.08% Market Closed
Market Cap: 17.2B USD

Intrinsic Value

0H7S price has not been updated for more than 1 month. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of 0H7S.

The Intrinsic Value is calculated as the average of DCF and Relative values:

0H7S Intrinsic Value
Not Available
Base Case Scenario
Compare 0H7S to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Abiomed's heavy reliance on the Impella platform for most of its revenue leaves the company vulnerable to any clinical setbacks, regulatory scrutiny, or new evidence suggesting limited patient benefits, which could sharply reduce demand.

Bull Theses

The Impella product line remains a category leader in percutaneous heart pump technology, backed by extensive clinical data and FDA indications, making it the go-to option for high-risk cardiovascular procedures.

Show More Less
How do you feel about 0H7S?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ABIOMED Inc

Current Assets 1.1B
Cash & Short-Term Investments 820.4m
Receivables 94.5m
Other Current Assets 148m
Non-Current Assets 633.7m
Long-Term Investments 289.1m
PP&E 202.7m
Intangibles 123.1m
Other Non-Current Assets 18.9m
Current Liabilities 134.1m
Accounts Payable 35.1m
Accrued Liabilities 66.6m
Other Current Liabilities 32.4m
Non-Current Liabilities 22.7m
Other Non-Current Liabilities 22.7m
Efficiency

Free Cash Flow Analysis
ABIOMED Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ABIOMED Inc

Revenue
1.1B USD
Cost of Revenue
-200.6m USD
Gross Profit
873.5m USD
Operating Expenses
-619.4m USD
Operating Income
254.1m USD
Other Expenses
12.7m USD
Net Income
266.8m USD
Fundamental Scores

0H7S Profitability Score
Profitability Due Diligence

ABIOMED Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Exceptional Gross Margin
Positive ROIC
Strong 3Y Average Gross Margin
hidden
Profitability
Score

ABIOMED Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

0H7S Solvency Score
Solvency Due Diligence

ABIOMED Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

ABIOMED Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0H7S Price Targets Summary
ABIOMED Inc

There are no price targets for 0H7S.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 0H7S is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y